Lillian F Soohoo, MD
Dermatology · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 27
- 7 carriers
- Office
- 1
Offices
1 location · Golden State Dermatology Associates, Inc. · 118 clinicians in this group
Plans that list them
27 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Soohoo’s office at (925) 932-7704 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A49205 · Current
Licensed to practise in California · since 1991 · expires 2027-01-31 · Case Western Reserve University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$99,197
Medicare paid this office $99,197 for 284 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 168 | $23,479 | $82 |
| Return visit (30+ min) | 118 | $18,741 | $122 |
| Biopsy of related skin growth, first growth | 78 | $9,629 | $101 |
| Destruction of precancer skin growth, 1 growth | 102 | $8,459 | $58 |
| New patient visit (45+ min) | 45 | $6,479 | $144 |
See all 11 services
| Short return visit (20+ min) | 168 | $23,479 | $82 |
| Return visit (30+ min) | 118 | $18,741 | $122 |
| Biopsy of related skin growth, first growth | 78 | $9,629 | $101 |
| Destruction of precancer skin growth, 1 growth | 102 | $8,459 | $58 |
| New patient visit (45+ min) | 45 | $6,479 | $144 |
| Application of light with debridement to destroy precancer skin growth | 16 | $5,217 | $326 |
| Destruction of precancer skin growth, 2-14 growths | 71 | $3,744 | $7 |
| Pathology examination of tissue using a microscope, intermediate complexity | 78 | $3,703 | $35 |
| New patient visit (30+ min) | 37 | $3,526 | $95 |
| Punch biopsy, first skin growth | 23 | $3,397 | $142 |
| Destruction of skin growth, 1-14 growths | 14 | $1,153 | $82 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 339 | More than 83% of doctors who do this |
| Skin biopsy | 127 | More than 79% of doctors who do this |
Who their Medicare patients are
284 Original Medicare patients in 2024. Average age 75 · Women 66% · Health risk score 0.80. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 66% · Coronary heart disease 21% · Diabetes 17% · Cancer 17% · Atrial fibrillation 13% · Depression 13% · Chronic kidney disease 12% · Heart failure 10% · Stroke 6% · COPD 5%.
The office billed $273,075, Medicare allowed $134,473 and paid $99,197; for 3,501 services of 34 kinds; $4,467 of it was for drugs given in the office and $94,730 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 284 | 3,501 | 75 | 0.80 | $273,075 | $99,197 |
| 2023 | 252 | 1,438 | 75 | 0.78 | $241,679 | $85,161 |
| 2022 | 245 | 1,244 | 76 | 0.80 | $197,292 | $75,284 |
| 2021 | 234 | 1,584 | 76 | 0.86 | $210,328 | $77,002 |
| 2020 | 210 | 1,202 | 76 | 0.98 | $162,512 | $57,120 |
| 2019 | 246 | 1,392 | 76 | 1.03 | $192,354 | $64,698 |
| 2018 | 211 | 1,458 | 75 | 0.94 | $191,300 | $67,259 |
| 2017 | 233 | 1,475 | 74 | 0.88 | $186,962 | $64,976 |
| 2016 | 231 | 1,566 | 75 | 0.98 | $189,902 | $67,268 |
| 2015 | 206 | 1,272 | 75 | 0.95 | $149,090 | $58,232 |
| 2014 | 237 | 1,324 | 74 | 0.82 | $151,126 | $62,444 |
| 2013 | 209 | 1,286 | 75 | 0.85 | $135,055 | $54,266 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Short return visit (20+ min) | 147 | $19,290 | $79 |
| Return visit (30+ min) | 101 | $13,788 | $110 |
| Destruction of precancer skin growth, 1 growth | 94 | $7,622 | $56 |
| Biopsy of related skin growth, first growth | 67 | $7,318 | $102 |
| New patient visit (45+ min) | 40 | $5,562 | $139 |
| New patient visit (30+ min) | 48 | $4,218 | $88 |
| Application of light with debridement to destroy precancer skin growth | 11 | $3,737 | $311 |
| Punch biopsy, first skin growth | 25 | $3,683 | $132 |
| Destruction of precancer skin growth, 2-14 growths | 70 | $3,662 | $7 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 11 | $3,622 | None |
| Destruction of skin growth, 1-14 growths | 27 | $2,699 | $100 |
| Pathology examination of tissue using a microscope, intermediate complexity | 55 | $2,349 | $34 |
2022: 10 services
| Short return visit (20+ min) | 156 | $15,220 | $73 |
| Return visit (30+ min) | 57 | $6,753 | $107 |
| Biopsy of related skin growth, first growth | 65 | $6,459 | $95 |
| Destruction of precancer skin growth, 1 growth | 81 | $5,121 | $50 |
| New patient visit (30+ min) | 45 | $3,636 | $81 |
| Pathology examination of tissue using a microscope, intermediate complexity | 72 | $2,928 | $35 |
| New patient visit (45+ min) | 20 | $2,800 | $140 |
| Destruction of precancer skin growth, 2-14 growths | 59 | $2,472 | $6 |
| Punch biopsy, first skin growth | 12 | $1,559 | $120 |
| Destruction of skin growth, 1-14 growths | 14 | $1,422 | $102 |
2021: 10 services
| Short return visit (20+ min) | 121 | $14,570 | $85 |
| Return visit (30+ min) | 89 | $13,465 | $113 |
| Biopsy of related skin growth, first growth | 75 | $8,635 | $105 |
| Destruction of precancer skin growth, 1 growth | 93 | $6,632 | $56 |
| Punch biopsy, first skin growth | 40 | $5,855 | $136 |
| Pathology examination of tissue using a microscope, intermediate complexity | 100 | $5,544 | $41 |
| New patient visit (30+ min) | 51 | $5,184 | $102 |
| New patient visit (45+ min) | 24 | $3,743 | $156 |
| Destruction of precancer skin growth, 2-14 growths | 75 | $3,661 | $7 |
| Biopsy of related skin growth, each additional growth | 12 | $845 | $56 |
2020: 9 services
| Return visit (30+ min) | 127 | $13,453 | $86 |
| Short return visit (20+ min) | 86 | $7,772 | $65 |
| Biopsy of related skin growth, first growth | 55 | $6,084 | $98 |
| New patient visit (30+ min) | 47 | $4,190 | $89 |
| Destruction of precancer skin growth, 1 growth | 66 | $4,125 | $51 |
| Pathology examination of tissue using a microscope, intermediate complexity | 70 | $3,041 | $35 |
| Punch biopsy, first skin growth | 20 | $2,751 | $131 |
| Destruction of skin growth, 1-14 growths | 20 | $2,569 | $99 |
| Destruction of precancer skin growth, 2-14 growths | 50 | $2,009 | $6 |
2019: 9 services
| Return visit (30+ min) | 156 | $18,633 | $89 |
| Short return visit (20+ min) | 121 | $12,982 | $67 |
| Destruction of precancer skin growth, 1 growth | 93 | $7,358 | $55 |
| Biopsy of related skin growth, first growth | 50 | $5,068 | $92 |
| Punch biopsy, first skin growth | 30 | $4,149 | $126 |
| Pathology examination of tissue using a microscope, intermediate complexity | 60 | $3,124 | $37 |
| Destruction of precancer skin growth, 2-14 growths | 76 | $2,978 | $6 |
| New patient visit (30+ min) | 37 | $2,741 | $74 |
| Destruction of skin growth, 1-14 growths | 21 | $2,562 | $102 |
2018: 8 services
| Return visit (30+ min) | 136 | $17,467 | $92 |
| Short return visit (20+ min) | 117 | $12,562 | $63 |
| Biopsy of single growth of skin and/or tissue | 76 | $9,408 | $98 |
| Destruction of precancer skin growth, 1 growth | 88 | $7,544 | $53 |
| New patient visit (30+ min) | 46 | $4,182 | $91 |
| Destruction of precancer skin growth, 2-14 growths | 73 | $3,247 | $5 |
| Destruction of skin growth, 1-14 growths | 26 | $3,053 | $109 |
| Pathology examination of tissue using a microscope, intermediate complexity | 55 | $2,421 | $36 |
2017: 8 services
| Return visit (30+ min) | 129 | $14,469 | $83 |
| Short return visit (20+ min) | 114 | $10,848 | $60 |
| Biopsy of single growth of skin and/or tissue | 70 | $7,651 | $93 |
| Destruction of precancer skin growth, 1 growth | 96 | $7,539 | $52 |
| New patient visit (30+ min) | 65 | $5,619 | $86 |
| Destruction of skin growth, 1-14 growths | 38 | $4,204 | $108 |
| Destruction of precancer skin growth, 2-14 growths | 69 | $3,507 | $5 |
| Pathology examination of tissue using a microscope, intermediate complexity | 58 | $2,669 | $36 |
2016: 8 services
| Return visit (30+ min) | 125 | $15,644 | $87 |
| Short return visit (20+ min) | 137 | $14,022 | $61 |
| Biopsy of single growth of skin and/or tissue | 69 | $8,216 | $93 |
| Destruction of precancer skin growth, 1 growth | 89 | $7,562 | $54 |
| New patient visit (30+ min) | 51 | $4,355 | $85 |
| Destruction of precancer skin growth, 2-14 growths | 73 | $3,630 | $5 |
| Destruction of skin growth, 1-14 growths | 32 | $3,235 | $98 |
| Pathology examination of tissue using a microscope, intermediate complexity | 53 | $2,716 | $38 |
2015: 8 services
| Short return visit (20+ min) | 159 | $18,359 | $60 |
| Destruction of precancer skin growth, 1 growth | 76 | $6,458 | $53 |
| Biopsy of single growth of skin and/or tissue | 55 | $6,381 | $97 |
| Return visit (30+ min) | 48 | $5,678 | $92 |
| New patient visit (30+ min) | 48 | $4,127 | $86 |
| Destruction of skin growth, 1-14 growths | 26 | $3,099 | $100 |
| Destruction of precancer skin growth, 2-14 growths | 58 | $2,641 | $5 |
| Pathology examination of tissue using a microscope, intermediate complexity | 47 | $2,182 | $36 |
2014: 9 services
| Short return visit (20+ min) | 192 | $21,940 | $61 |
| Destruction of precancer skin growth, 1 growth | 80 | $8,475 | $63 |
| Biopsy of single growth of skin and/or tissue | 69 | $7,279 | $92 |
| New patient visit (30+ min) | 67 | $5,820 | $87 |
| Destruction of precancer skin growth, 2-14 growths | 57 | $4,629 | $10 |
| Destruction of skin growth, 1-14 growths | 24 | $2,819 | $101 |
| Pathology examination of tissue using a microscope, intermediate complexity | 51 | $2,701 | $38 |
| Return visit (30+ min) | 11 | $1,461 | $91 |
| Short return visit | 20 | $747 | $37 |
2013: 9 services
| Short return visit (20+ min) | 163 | $17,208 | $60 |
| Destruction of precancer skin growth, 1 growth | 71 | $7,787 | $71 |
| Biopsy of single growth of skin and/or tissue | 63 | $6,866 | $95 |
| New patient visit (30+ min) | 60 | $5,070 | $84 |
| Destruction of precancer skin growth, 2-14 growths | 52 | $3,570 | $6 |
| Destruction of skin growth, 1-14 growths | 24 | $2,851 | $110 |
| Pathology examination of tissue using a microscope, intermediate complexity | 52 | $2,359 | $36 |
| Return visit (30+ min) | 15 | $1,696 | $100 |
| Short return visit | 18 | $586 | $31 |
Drugs they prescribed that Part D paid
$124,447
Pharmacies billed $124,447 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 483) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
438 generic and 45 brand-name prescriptions · $124,447 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 13 | $48,646 | $3,742 |
| Doxycycline Ir-Dr | 16 | $9,649 | $603 |
| Ciclopirox | 126 | $3,114 | $25 |
| Fluconazole | 24 | $1,565 | $65 |
| Fluocinolone Acetonide | 11 | $778 | $71 |
See all 10 drugs
| Dupixent | 13 | $48,646 | $3,742 |
| Doxycycline Ir-Dr | 16 | $9,649 | $603 |
| Ciclopirox | 126 | $3,114 | $25 |
| Fluconazole | 24 | $1,565 | $65 |
| Fluocinolone Acetonide | 11 | $778 | $71 |
| Desonide | 27 | $720 | $27 |
| Mupirocin | 94 | $701 | $7 |
| Ketoconazole | 43 | $489 | $11 |
| Mometasone Furoate | 27 | $387 | $14 |
| Clobetasol Propionate | 12 | $281 | $23 |
Year by year
| 2024 | 483 | 187 | 0% (0) | 9% | $124,447 |
| 2023 | 369 | 138 | 0% (0) | 11% | $94,486 |
| 2022 | 261 | 122 | 0% (0) | None | $14,623 |
| 2021 | 258 | 118 | 0% (0) | None | $7,703 |
| 2020 | 302 | 107 | 0% (0) | 5% | $13,924 |
| 2019 | 319 | 158 | None | 4% | $11,494 |
| 2018 | 301 | 126 | None | 10% | $14,346 |
| 2017 | 298 | 101 | None | 7% | $12,762 |
| 2016 | 265 | 108 | None | 9% | $16,179 |
| 2015 | 233 | 99 | None | 12% | $15,650 |
| 2014 | 226 | 94 | None | 15% | $17,653 |
| 2013 | 176 | 76 | None | 16% | $10,881 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Olumiant | 13 | $41,214 | $3,170 |
| Ciclopirox | 58 | $2,613 | $45 |
| Fluocinolone Acetonide | 14 | $1,172 | $84 |
| Fluconazole | 16 | $1,063 | $66 |
| Ketoconazole | 57 | $812 | $14 |
| Mupirocin | 89 | $763 | $9 |
| Mometasone Furoate | 22 | $480 | $22 |
| Desonide | 12 | $412 | $34 |
2022: 5 drugs
| Ciclopirox | 26 | $774 | $30 |
| Mupirocin | 77 | $632 | $8 |
| Ketoconazole | 37 | $498 | $13 |
| Doxycycline Monohydrate | 13 | $473 | $36 |
| Mometasone Furoate | 18 | $467 | $26 |
2021: 6 drugs
| Mupirocin | 82 | $860 | $10 |
| Fluocinolone Acetonide | 13 | $789 | $61 |
| Ciclopirox | 22 | $741 | $34 |
| Ketoconazole | 40 | $655 | $16 |
| Mometasone Furoate | 23 | $402 | $17 |
| Cephalexin | 12 | $84 | $7 |
2020: 8 drugs
| Halobetasol Propionate | 20 | $1,428 | $71 |
| Fluocinolone Acetonide | 17 | $953 | $56 |
| Ciclopirox | 31 | $889 | $29 |
| Desonide | 12 | $877 | $73 |
| Ketoconazole | 56 | $820 | $15 |
| Mometasone Furoate | 32 | $733 | $23 |
| Doxycycline Monohydrate | 11 | $571 | $52 |
| Mupirocin | 59 | $483 | $8 |
2019: 7 drugs
| Halobetasol Propionate | 14 | $1,695 | $121 |
| Ciclopirox | 27 | $1,233 | $46 |
| Mupirocin | 101 | $996 | $10 |
| Mometasone Furoate | 28 | $829 | $30 |
| Ketoconazole | 32 | $618 | $19 |
| Triamcinolone Acetonide | 20 | $202 | $10 |
| Hydrocortisone | 15 | $58 | $4 |
2018: 8 drugs
| Halobetasol Propionate | 13 | $1,786 | $137 |
| Minocycline | 16 | $1,421 | $89 |
| Mupirocin | 98 | $899 | $9 |
| Mometasone Furoate | 23 | $786 | $34 |
| Ciclopirox | 11 | $638 | $58 |
| Ketoconazole | 29 | $460 | $16 |
| Triamcinolone Acetonide | 16 | $187 | $12 |
| Cephalexin | 11 | $87 | $8 |
2017: 6 drugs
| Mupirocin | 99 | $816 | $8 |
| Ciclopirox | 12 | $513 | $43 |
| Ketoconazole | 23 | $480 | $21 |
| Mometasone Furoate | 16 | $459 | $29 |
| Triamcinolone Acetonide | 17 | $117 | $7 |
| Cephalexin | 17 | $117 | $7 |
2016: 7 drugs
| Minocycline | 24 | $2,128 | $89 |
| Halobetasol Propionate | 19 | $1,515 | $80 |
| Mupirocin | 68 | $631 | $9 |
| Mometasone Furoate | 13 | $496 | $38 |
| Ketoconazole | 23 | $451 | $20 |
| Fluconazole | 11 | $435 | $40 |
| Cephalexin | 13 | $125 | $10 |
2015: 7 drugs
| Halobetasol Propionate | 21 | $2,719 | $129 |
| Desonide | 15 | $2,447 | $163 |
| Fluocinolone Acetonide | 11 | $1,715 | $156 |
| Minocycline | 13 | $871 | $67 |
| Mupirocin | 54 | $598 | $11 |
| Ketoconazole | 28 | $313 | $11 |
| Cephalexin | 15 | $67 | $4 |
2014: 7 drugs
| Halobetasol Propionate | 28 | $3,544 | $127 |
| Desonide | 18 | $2,806 | $156 |
| Clobetasol Propionate | 13 | $1,587 | $122 |
| Mupirocin | 49 | $476 | $10 |
| Minocycline | 15 | $365 | $24 |
| Ketoconazole | 20 | $231 | $12 |
| Cephalexin | 17 | $106 | $6 |
2013: 6 drugs
| Halobetasol Propionate | 16 | $1,286 | $80 |
| Clobetasol Propionate | 15 | $1,101 | $73 |
| Desonide | 13 | $731 | $56 |
| Mupirocin | 41 | $552 | $13 |
| Minocycline | 12 | $360 | $30 |
| Cephalexin | 18 | $107 | $6 |
Money from drug and device companies
$2,336 in 2025
| 2025 | 16 | 79 | None | $2,336 |
| 2024 | 16 | 123 | None | $3,464 |
| 2023 | 18 | 89 | None | $2,898 |
| 2022 | 13 | 28 | None | $843 |
| 2021 | 7 | 15 | None | $364 |
| 2020 | 7 | 22 | None | $506 |
| 2019 | 12 | 26 | None | $894 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Dupixent | $592 | 11 payments
|
| Abbvie | Rinvoq | $403 | 18 payments
|
| Regeneron Healthcare Solutions | Dupixent | $377 | 13 payments
|
| Lilly USA | Taltz | $225 | 9 payments
|
| Galderma Laboratories L.P. | Nemluvio | $173 | 6 payments
|
| Revance Therapeutics | Daxi | $91 | 3 payments
|
See all 79 published payments
| Revance Therapeutics | Meals · 2025-12-16 | None | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-12-11 | Dupixent | $20 |
| Abbvie | Meals · 2025-10-16 | Skyrizi | $13 |
| Novartis Pharmaceuticals | Meals · 2025-10-14 | Cosentyx | $16 |
| Janssen Biotech | Meals · 2025-10-10 | Tremfya | $35 |
| Abbvie | Meals · 2025-10-08 | Botox | $28 |
| Genzyme | Meals · 2025-10-08 | Dupixent | $18 |
| Lilly USA | Meals · 2025-10-03 | Taltz | $8 |
| Lilly USA | Meals · 2025-10-03 | Taltz | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-10-02 | Dupixent | $31 |
| Genzyme | Meals · 2025-09-29 | Dupixent | $83 |
| Genzyme | Meals · 2025-09-24 | Dupixent | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-09-18 | Dupixent | $13 |
| Lilly USA | Meals · 2025-09-17 | Taltz | $33 |
| Regeneron Healthcare Solutions | Education · 2025-09-17 | Dupixent | $85 |
| Galderma Laboratories L.P. | Meals · 2025-08-26 | Nemluvio | $17 |
| Lilly USA | Meals · 2025-08-22 | Taltz | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-08-22 | Dupixent | $17 |
| Arcutis Biotherapeutics | Meals · 2025-08-21 | Zoryve | $18 |
| Arcutis Biotherapeutics | Meals · 2025-08-21 | Zoryve | $17 |
| Abbvie | Meals · 2025-08-20 | Rinvoq | $29 |
| Genzyme | Meals · 2025-08-15 | Dupixent | $34 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $32 |
| Abbvie | Meals · 2025-08-09 | Skyrizi | $10 |
| Arcutis Biotherapeutics | Meals · 2025-08-06 | Zoryve | $18 |
| Lilly USA | Meals · 2025-08-01 | Taltz | $27 |
| Botanix SB | Meals · 2025-06-27 | Sofdra | $21 |
| Abbvie | Meals · 2025-06-26 | Botox | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-06-26 | Dupixent | $29 |
| Lilly USA | Meals · 2025-06-24 | Taltz | $23 |
| Lilly USA | Meals · 2025-06-12 | Taltz | $32 |
| Abbvie | Meals · 2025-06-11 | Rinvoq | $28 |
| Incyte | Meals · 2025-06-05 | Opzelura | $15 |
| LEO Pharma | Meals · 2025-06-05 | Adbry | $30 |
| Galderma Laboratories L.P. | Meals · 2025-05-31 | Nemluvio | $14 |
| Genzyme | Meals · 2025-05-30 | Dupixent | $31 |
| Genzyme | Meals · 2025-05-29 | Dupixent | $124 |
| Galderma Laboratories L.P. | Meals · 2025-05-24 | Nemluvio | $31 |
| Abbvie | Meals · 2025-05-22 | Rinvoq | $33 |
| Genzyme | Meals · 2025-05-21 | Dupixent | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-05-17 | Dupixent | $27 |
| Abbvie | Meals · 2025-05-14 | Skyrizi | $9 |
| Incyte | Meals · 2025-05-08 | Opzelura | $29 |
| Regeneron Healthcare Solutions | Meals · 2025-05-03 | Dupixent | $23 |
| Galderma Laboratories L.P. | Meals · 2025-05-03 | Nemluvio | $36 |
| Revance Therapeutics | Meals · 2025-04-29 | Daxi | $33 |
| Almirall | Meals · 2025-04-24 | Klisyri | $31 |
| Sun Pharmaceutical Industries | Meals · 2025-04-24 | Winlevi | $29 |
| Lilly USA | Meals · 2025-04-23 | Taltz | $23 |
| Abbvie | Meals · 2025-04-22 | Skyrizi | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-04-18 | Dupixent | $28 |
| Abbvie | Meals · 2025-04-12 | Rinvoq | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-10 | Sotyktu | $27 |
| Abbvie | Meals · 2025-04-04 | Rinvoq | $29 |
| Genzyme | Meals · 2025-03-28 | Dupixent | $39 |
| Lilly USA | Meals · 2025-03-27 | Taltz | $31 |
| Genzyme | Meals · 2025-03-27 | Dupixent | $146 |
| Abbvie | Meals · 2025-03-26 | Skyrizi | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-03-22 | Dupixent | $27 |
| Abbvie | Meals · 2025-03-21 | Skyrizi | $10 |
| Almirall | Meals · 2025-03-19 | Klisyri | $33 |
| Abbvie | Meals · 2025-03-15 | Rinvoq | $32 |
| Incyte | Meals · 2025-03-14 | Opzelura | $29 |
| Genzyme | Meals · 2025-03-14 | Dupixent | $38 |
| Regeneron Healthcare Solutions | Meals · 2025-03-08 | Dupixent | $28 |
| Galderma Laboratories L.P. | Meals · 2025-03-07 | Nemluvio | $35 |
| Genzyme | Meals · 2025-02-28 | Dupixent | $34 |
| Revance Therapeutics | Meals · 2025-02-27 | None | $28 |
| Abbvie | Meals · 2025-02-26 | Skyrizi | $24 |
| Abbvie | Meals · 2025-02-20 | Skyrizi | $8 |
| Galderma Laboratories L.P. | Meals · 2025-02-20 | Nemluvio | $41 |
| Regeneron Healthcare Solutions | Meals · 2025-02-08 | Dupixent | $21 |
| Organon | Meals · 2025-02-06 | Vtama | $32 |
| Organon | Meals · 2025-02-04 | Vtama | $8 |
| Abbvie | Meals · 2025-01-17 | Skyrizi | $18 |
| Abbvie | Meals · 2025-01-17 | Rinvoq | $35 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-14 | Sotyktu | $29 |
| Almirall | Meals · 2025-01-11 | Klisyri | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-01-08 | Dupixent | $30 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,464
| Abbvie | Skyrizi | $758 | 36 payments
|
| Regeneron Healthcare Solutions | Dupixent | $586 | 16 payments
|
| Sun Pharmaceutical Industries | Winlevi | $402 | 15 payments
|
| Revance Therapeutics | Daxxify | $346 | 7 payments
|
| Genzyme | Dupixent | $235 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $185 | 9 payments
|
| Dermavant Sciences | Vtama | $178 | 7 payments
|
| Janssen Biotech | Tremfya | $166 | 4 payments
|
| Almirall | Klisyri | $120 | 4 payments
|
| Galderma Laboratories L.P. | Aklief | $120 | 4 payments
|
| Pfizer | Eucrisa | $113 | 4 payments
|
| Arcutis Biotherapeutics | Zoryve | $58 | 2 payments
|
| Lilly USA | Taltz | $56 | 2 payments
|
| Incyte | Opzelura | $56 | 2 payments
|
| LEO Pharma | Adbry | $55 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $31 | 1 payment
|
2023: $2,898
| AbbVie | Rinvoq | $615 | 19 payments
|
| Regeneron Healthcare Solutions | Dupixent | $406 | 13 payments
|
| Sun Pharmaceutical Industries | Winlevi | $250 | 12 payments
|
| Arcutis Biotherapeutics | None | $234 | 7 payments
|
| Genzyme | Dupixent | $228 | 5 payments
|
| Dermavant Sciences | Vtama | $196 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $192 | 4 payments
|
| Merz North America | Xeomin | $185 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $148 | 9 payments
|
| Incyte | Opzelura | $97 | 4 payments
|
| Medtronic | Percept PC Brainsense | $91 | 1 payment
|
| Fresenius Kabi USA | Idacio | $63 | 2 payments
|
| Almirall | Klisyri | $61 | 2 payments
|
| Lilly USA | Taltz | $34 | 1 payment
|
| Amgen | Otezla | $31 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $30 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $18 | 1 payment
|
| Biofrontera | Ameluz | $17 | 1 payment
|
2022: $843
| Abbvie | Humira | $269 | 12 payments
|
| Horizon Therapeutics plc | Tepezza | $117 | 1 payment
|
| Medtronic | Venaseal | $111 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $78 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $75 | 4 payments
|
| Merz North America | Xeomin | $36 | 1 payment
|
| Allergan | Botox | $29 | 1 payment
|
| Incyte | Opzelura | $27 | 1 payment
|
| Lilly USA | Taltz | $23 | 1 payment
|
| Janssen Biotech | Remicade | $22 | 1 payment
|
| Galderma Laboratories L.P. | None | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $18 | 1 payment
|
| Solta Medical a division of Bausch Health US | None | $17 | 1 payment
|
2021: $364
| AbbVie | Skyrizi | $134 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $93 | 1 payment
|
| Janssen Biotech | Remicade | $46 | 3 payments
|
| LEO Pharma | Enstilar | $39 | 2 payments
|
| Galderma Laboratories L.P. | None | $22 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $17 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $12 | 1 payment
|
2020: $506
| Galderma Laboratories L.P. | None | $140 | 8 payments
|
| Janssen Biotech | Tremfya | $111 | 7 payments
|
| Regeneron Healthcare Solutions | Dupixent | $80 | 1 payment
|
| Janssen Scientific Affairs | Tremfya | $71 | 1 payment
|
| AbbVie | Skyrizi | $43 | 2 payments
|
| Mayne Pharma | Doryx | $40 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $20 | 1 payment
|
2019: $894
| Ucb | Cimzia | $171 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $125 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $125 | 1 payment
|
| Genentech USA | Erivedge | $120 | 5 payments
|
| Janssen Biotech | Tremfya | $118 | 6 payments
|
| Sun Pharmaceutical Industries | Ilumya | $106 | 1 payment
|
| Allergan | Botox Cosmetic | $39 | 2 payments
|
| AbbVie | Humira | $36 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $20 | 1 payment
|
| LEO Pharma | Enstilar | $16 | 1 payment
|
| Merck Sharp & Dohme | Sivextro | $14 | 1 payment
|
| Sensus Healthcare | None | $3 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629140819
- Licence
- CA A49205California A49205: Current · expires 2027-01-31
- Trained
- Clvlnd Clinic Lerner College of Med of Case Wstn Rsv University, 1989
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 174400000X (174400000X)
- Mailing address
- Po Box 1497, L, Los Gatos, CA, 95031
- NPI first listed
- 2006-11-14
- NPI last updated
- 2008-10-01
This is when the NPI record was last certified, not a medical board exam.